Objective: Small proteoglycans (PGs) may accumulate in late stage osteoarthritis even as aggrecan is lost. It is not clear what role transforming growth factor (TGF) beta has in this accumulation. Our goal was to investigate the ability of TGF beta 1 to modulate the synthesis and accumulation of decorin, biglycan, and fibromodulin in cartilage explants cultured under conditions in which aggrecan synthesis remains relatively constant.
Introduction
Decorin, biglycan, and fibromodulin are members of the small, leucine-rich proteoglycan (PGs) (SLRP) family of proteins and are located in articular cartilage as well as in other tissues 1, 2 . Both decorin and fibromodulin have been localized by electron microscopy to collagen fibrils in carti-lage. In in vitro studies, decorin and fibromodulin influence the rate and extent of collagen type I fibrillogenesis. A direct role in control of type I collagen fibrillogenesis in the tendon has been confirmed for fibromodulin by observation of fibromodulin-null mice 3 and for decorin, both by observations of decorin-deficient mice 4 and by disruption of decorin-fibronectin-collagen interactions in vivo using blocking peptides 5 . Thus, it is reasonable to think that the function of decorin and fibromodulin in cartilage is to regulate the diameter and organization of collagen fibrils, although this has not been directly confirmed.
Decorin, biglycan, and fibromodulin bind to active transforming growth factor (TGF) betas 1, 2 and 3 via their core proteins, with both high-affinity and low-affinity binding sites 6 . The chondroitin/dermatan sulfate chains of decorin and biglycan appear to somewhat hinder this binding, making TGF beta binding to fibromodulin more effective than binding to decorin or biglycan within the tissue. In the study by Hildebrand et al. 6 , this binding was specific for TGF beta out of several other growth factors tested and suggests an important role for these small PGs in regulating the activity of TGF beta on the synthesis of matrix components. Studies by Markmann et al. 7 suggest that decorin must be bound to matrix in order to sequester and inactivate TGF beta.
In turn, TGF beta contributes to the regulation of the synthesis of the small PGs. This has been studied in chondrocyte cell cultures. Several investigators have reported that TGF betas increase the synthesis of the small PGs in cultures of isolated chondrocytes. Decorin and biglycan have typically been the focus of these studies, but reports have been inconsistent as to whether one or the other, or both are elevated. Roughley et al. 8 reported a decrease in decorin mRNA in chondrocytes cultured with TGF beta in monolayers and Demoor-Fossard 9 reported that TGF beta inhibited decorin synthesis in chondrocyte monolayers, but not in chondrocytes in alginate beads. There is no information about the effect of TGF beta on fibromodulin in chondrocytes, with the exception of preliminary data showing two-fold increases in fibromodulin at the RNA and protein level in chondrocytes cultured in alginate beads 10 .
Recent studies have focused on the SLRP in osteoarthritic cartilage. In vivo, Cs-Szabó et al. 11 have shown that mRNA for aggrecan, decorin, biglycan, and fibromodulin are increased in human knee osteoarthritis (OA), while Dourado et al. 12 reported similar increases for the canine anterior cruciate ligament transection model. Both laboratories reported greater changes in biglycan than in decorin (10:5.8 and 3.9:1.2, respectively). Fibromodulin mRNA was reported to increase by 11.5-and 2.4-fold, respectively. Cs-Szabó reported comparable increases at the protein level as well as for decorin, biglycan, and fibromodulin. Little et al. 13 reported increased decorin and biglycan synthesis in lateral tibial and femoral cartilage after a lateral meniscectomy in sheep. Most recently, Bock et al. 14 reported increased transcription and translation of both decorin and biglycan in late stage human OA, with highest levels in areas adjacent to the lesion. On the other hand, Poole et al. 15 reported no overall differences in biglycan and decorin contents in human knee OA, although loss from the superficial layers of osteoarthritic cartilage was greater.
A role for TGF betas and small PGs, possibly related, in OA progression is under consideration. TGF beta has been implicated in synovitis 16 , in OA progression 17, 18 , and osteophyte formation. Furthermore, chondrocytes from OA cartilage may be more responsive to TGF beta than normal chondrocytes 19 . The accumulation of small PGs in human cartilage in late stage OA 11 would increase the potential to bind and sequester TGF beta and possibly mitigate effects on OA 6 . However, bound and sequestered TGF beta would fail to stimulate synthesis of the small PGs and other matrix components required to maintain a healthy cartilage. Thus, the consequences are really not known, and could be positive or negative outcomes for OA.
Studies that have been done to better define the relationship among TGF beta, chondrocyte synthesis of small PGs, and OA have not been altogether consistent, but at least some of the confusion must be attributed to the focus on chondrocytes in culture. Chondrocytes in monolayer rapidly dedifferentiate. Even chondrocytes in three-dimensional cultures fail to mimic the in vivo chondrocyte in all respects 20 . Explant cultures, with intact, native matrix, provide conditions closer to in vivo. Our laboratory has a well-characterized explant culture system in which aggrecan remains constant, but fibronectin, an early marker of degenerating cartilage, accumulates 21 . Preliminary data suggested increased synthesis of total small PGs as well. Our goal was to determine the effect of TGF beta 1 individually on each of the small PGs, decorin, biglycan, and fibromodulin, in this system. Antibodies to canine biglycan and decorin 10 and crossreactive purified polyclonal antibody raised against a C-terminal amino acid sequence of human fibromodulin 22 were prepared. Canine biglycan and decorin cDNAs were sequenced and specific peptide sequences were selected from the C-terminal of biglycan and decorin (Gene bank accession numbers: Canine biglycan, U83140; Canine decorin, U83141). Synthetic peptides were coupled with ovalbumin and injected to rabbits. Polyclonal anti-sera were purified on affinity columns on which the corresponding peptides were bound 10 . The anti-human fibromodulin antibody preparation has been described previously 22 and cross-reacted with canine fibromodulin. The anti-decorin monoclonal antibody, 6D6 23, 24 , used for immunoprecipitation, was the gift of Dr Paul Scott (Edmonton, Alberta, Canada). Nitrocellulose membranes were obtained from Osmonics (Westborough, MA). Hybond™-N + membranes were obtained from Amersham Pharmacia Biotech Limited (Little Chalfont, Buckinghamshire, England).
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EXPLANT CULTURE
Source of explant cartilage
The sources of cartilage were Labrador Retrievers or Labrador Retriever-Greyhound crosses from a colony maintained at the James A. Baker Institute for Animal Health and bred for the study of genetic markers of canine hip dysplasia and its concomitant OA. Dogs ranged in age from 8 to 28 months.
Culture conditions
Cartilage was obtained at necropsy from Labrador retrievers from our colony of dogs with individuals at high and low risk for developing OA. Only macroscopically diseasefree cartilage was removed aseptically from the hip, knee, or shoulder joints of these Labrador Retriever dogs and placed into Gey's balanced salt solution; however, some cartilage sampled may be predisposed for development of cartilage damage 25, 26 . The cartilage was rinsed three times 168 N. Burton-Wurster et al.: TGF beta and canine small proteoglycans and approximately 50 mg was placed into screw-capped vials or 24-well tissue culture dishes (Corning, NY) containing 2 ml of the appropriate culture medium. All explants were incubated in Hams F 12 nutrient medium supplemented with ITSCR + and with CaCl 2 21 . In some experiments, Na 2 SO 4 was added to a concentration of 0.3 or 1.6 mM to be certain that available sulfate was not limiting for PG synthesis. Cartilage was cultured for 1 or 15 days with 4 ng/ml TGF beta 1, following 1-2 days of preincubation. Controls were cultured for the same length of time in the absence of TGF beta. The dosage chosen is physiologically relevant. TGF beta 1 levels in synovial fluids from OA patients varied widely in one study, reaching as high as 10 ng/ml and averaging to about 2.5 ng/ml 27 . Furthermore, 4 ng/ml of TGF beta was shown previously to stimulate aggrecan synthesis under the basal conditions 28 , but not under the serum-free supplementation used in these experiments 21 . However, at this dosage, the synthesis of other proteins, especially fibronectin, is markedly affected 21 . In preliminary experiments, addition of vehicle alone had no effect on cartilage metabolism. Medium was changed every 3 or 4 days at which time fresh TGF beta was added. Radioactive precursors ( 35 SO 4 or 3 H-leucine plus 35 S-methionine) were added to the culture on the day before harvest. After an overnight incubation, explants were washed three times with Gey's balanced salt solution and frozen until further analyses. To determine total PG synthesis, the cartilage residue after extraction was digested with 1 mg/ml papain in 0.05 M phosphate buffer containing 0.0326% N-acetylcysteine and 2 mM EDTA at 60°C for 4 h, and aliquots of digests and extracts were added to Ecoscint (National Diagnostics, Atlanta, GA) and quantitated in a Beckman LS6800 liquid scintillation counter. Total sulfated glycosaminoglycans (GAG) in the extracts and papain digests were determined by the dimethylmethylene blue (DMMB) assay of 
Release of free GAG chains
To analyze free GAG chains, guanidinium chloride extracts were subject to gel filtration chromatography on Sepharose CL6B. Fractions corresponding to aggrecan and to the small PGs with GAG substitution were pooled separately, transferred to digest buffer and digested for 4 h at 60°C with 0.5 mg/ml papain. The samples were centrifuged and made 5% with potassium acetate in 95% ethanol. The 35 SO 4 -GAGs were precipitated over 2 days at 4°C and then washed with ethanol, dried, redissolved in distilled, deionized water, prepared for electrophoresis, and were detected by autoradiography.
Immunoprecipitation of decorin
The 0.3 M NaCl fractions from DEAE anion exchange columns were transferred to a dilution buffer (10 mM phosphate buffer, pH 7.2, containing 0.5% Na deoxycholate, 1% Triton X-100, 0.1% SDS, 100 mM NaCl, and 1 mM EDTA) and incubated overnight with monoclonal antibody 6D6 or with a control antibody at 4°C. The immune complex was precipitated with protein G agarose. Samples were then washed three times in 20 mM Tris buffer, pH 8.8, containing 0.5% Na deoxycholate, 0.5% NP 40, 50 mM NaCl, 2 mM PMSF, and 2 mM EDTA. Immunoprecipitated small PGs were resolved by SDS gradient gel electrophoresis 30 after heating at 95°C for 10 min in digestion buffer (50 mM Tris, pH 6.8, 2% SDS, 2 mM PMSF, and 2 mM EDTA), and were visualized by autoradiography.
PURIFICATION, CHARACTERIZATION, AND QUANTITATION OF ENDOGENOUS SMALL PGS
For purification, characterization, and quantitation of total decorin, biglycan, and fibromodulin, the guanidinium chloride extracts were directly analyzed by Western analysis before and after enzymatic digestion.
Enzymatic digestion
For the analysis of biglycan, decorin, and fibromodulin core proteins, samples of the extracts (20-40 µg dry weight) were dialyzed to 0.1 M Tris, 0.05 M Na-acetate, pH 7.3, and were digested with 20 mU proteinase-free chondroitinase ABC (Seikagaku) at 37°C overnight to remove chondroitin sulfate or dermatan sulfate side chains from the core proteins of decorin and biglycan. After adjusting the pH to 6.0, one-half of the samples were further digested with Keratanase II (Seikagaku) in the presence of proteinase inhibitors at 37°C overnight, to remove keratan sulfate (KS) side chains from the core protein of fibromodulin. One-half of this sample was further digested with N-glycanase [PNGase F; New England BioLabs, Inc. (Beverly, MA)] according to the manufacturer's instructions, to remove N-linked substitution from the core proteins of fibromodulin.
SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE), AUTORADIOGRAPHY, AND WESTERN BLOTTING
Small PGs and their core proteins were separated in 12% uniform or 4-15% gradient slab gels under reducing conditions using the Tris/glycine buffer system described by Laemmli 31 . Gels were stained with Coomassie brilliant blue and/or toluidine blue, or were electrophoretically transferred onto nitrocellulose for free core proteins or onto Hybond-N + nylon membranes for native PGs.
Autoradiography
Stained gels were dried and exposed to a phosphorimager screen. Radioactive PGs and core proteins were quantitated using MACBAS software (Fuji Medical Systems USA, Stamford, CT) after scanning in the Fujix B 10 -Imaging Analyzer.
Western blot hybridization
Membranes containing transferred proteins were blocked with 5% milk in Tris buffered saline containing Tween 20, and were probed with antibodies to decorin, biglycan, or fibromodulin followed by peroxidase-labeled goat antirabbit IgG and visualized by enhanced chemiluminescence assay (ECL) followed by quantitation of the signal on ECL films by a BioRad image analyzer.
STATISTICAL METHODS
Results were analyzed by ANOVA, general linear model, using MINITAB software (Kent, Boston, MA). Significance was set at P<0.05.
Results
PROTEOGLYCAN SYNTHESIS IN CARTILAGE EXPLANTS
When cartilage explants were cultured in the presence of TGF beta 1 and supplemented with insulin and calcium, total 35 SO 4 -PG was unchanged or only modestly increased, but 35 SO 4 -PG in a 4 M urea extract was increased several folds with respect to control cultures (Table I) . Analysis of urea extracts by gel filtration chromatography, DEAE chromatography, and gradient gel electrophoresis showed that 35 (Fig. 1, lanes 4 and 6) . Explant culture was continued for an additional 14 days in the presence or absence of TGF beta 1. By day 16, synthesis of 35 SO 4 -small PGs was increased in TGF betatreated samples. A three-fold increase in total small PG synthesis relative to day 2 controls (4471/1566, Table II) , and as much as a nine-fold increase relative to day 16 Table II ), were noted. Furthermore, much of the small PG synthesized after 16 days of culture in the presence of TGF beta 1 had a higher molecular weight (HMW) than that of decorin found in the controls (Fig. 1 , lanes 2 and 8; Table II ). It was extracted from cartilage by either urea or guanidinium chloride, and was eluted from DEAE anion exchange columns in both the 0.3 and 1.0 M NaCl fractions. Although 35 SO 4 -small PG synthesis decreased in the controls, a small shift in molecular weight was also evident (Table II) . The GAG chains of the HMW small PG synthesized in the presence of TGF beta 1 were sensitive to chondroitinase ABC digestion (Fig. 1, lanes 1 and 7) , and the core proteins were identical in electrophoretic mobility to those obtained from the small PGs synthesized in the controls (Fig. 1, lanes 5  and 7) . The data are consistent with identification of the HMW 35 SO 4 -PG as decorin with a longer GAG chain. The newly synthesized, HMW small PG could be immunoprecipitated by an anti-decorin antibody (not shown). Electrophoretic analysis of the free GAG chains after papain digestion indicated that GAG chains on the small PGs from TGF beta-treated samples ranged from 25 to 50 kDa and, on average, were 1.5 times the size of the GAG chains from the small PGs synthesized in day 2 controls and twice the size of the GAG chains from all aggrecans (not shown). Furthermore, when synthesis of core proteins were followed with radioactive amino acid precursors, an increase in total small PG synthesis was confirmed. The increase in 35 SO 4 -GAG in response to TGF beta exceeded the increase in 3 H/ 35 S-core protein by 1.4-fold, entirely consistent with an increase in GAG chain length in addition to a total increase in synthesis (not shown). 35 SO 4 -biglycan, which eluted from DEAE columns with both 0.3 and 1 M NaCl was present at lower levels than decorin, and was not always clearly separated from the top of the gel. It was not further characterized. Fibromodulin substituted with KS has a mobility similar to decorin. Little or no 35 SO-PG or 3 H/ 35 S-PG remained after digestion with chondroitinase ABC (Fig. 1 ), suggesting that newly synthesized fibromodulin was below detectable levels in these experiments. However, N-linked oligosaccharidesubstituted forms of fibromodulin lacking sulfate would elute from DEAE columns at lower salt concentrations, less than 0.3 M. Although small amounts of 3 H/ 35 S-proteins consistent with N-linked oligosaccharide-substituted fibromodulin were found in the 0.2 M NaCl fraction, they were not positively identified.
CHARACTERIZATION AND QUANTITATION OF TOTAL ENDOGENOUS SMALL PGS BY WESTERN ANALYSIS AND CHEMILUMINESCENCE
Characterization by size and extent of glycosylation
The total decorin present after 16 days in control and TGF beta 1-treated cultures were very similar in mobility when identified by an anti-decorin antibody in Western analysis (Fig. 2, panel 1) , although small amounts of a HMW decorin were detected by Western analysis in TGF beta 1-treated cultures in some experiments (Fig. 2, panel  1, lanes 3 and 4, arrowheads) . This decorin approached the size of the newly synthesized decorin revealed by isotope labeling. After digestion with chondroitinase ABC, the sizes of the core proteins from control and TGF beta-treated cultures were identical (Fig. 2, panel 2) , consistent with data shown for newly synthesized decorin in Fig. 1 . Most decorin was found with the GAG attached, although a small amount of decorin-free core protein was detected. In contrast, both native biglycan, with GAG attached as well as free-biglycan core protein, were detected in explanted cartilage (data not shown).
Native fibromodulins consisted of a diffuse population of molecules ranging from approximately 60 to 100 kDa as is the characteristic of KS substitution (Fig. 3, panel 1) , and also of a more discrete population near 66 kDa, which can be seen more clearly when the native molecule is blotted to nitrocellulose (Fig. 3, panel 2) . When sulfated GAGs (KS) were removed by enzymatic digestion from the core protein, a more compact band was detected at 66 kD indicating that the original sample did contain a subpopulation of the core protein which was substituted with KS ( Fig. 3,  panel 3 ). However, further removal of N-linked substituents from the core protein with N-glycanase revealed that the majority of the core protein was substituted with N-linked oligosaccharide. After this step, fibromodulin was detected as a major band at 46 kD and a minor band at 40 kD (Fig.  3, panel 4) . These species were not detected in the native extract; thus, fibromodulin is present in substituted KS-, and N-linked oligosaccharide-substituted forms, but not as a free-core protein. The total amounts of fibromodulin changed as a result of TGF beta 1 treatment, but the substitution of fibromodulin was similar in both control and TGF beta 1-treated cultures.
Quantitation of total endogenous small PGs
For quantitation of total accumulated endogenous small PGs (native as well as free-core protein), GAG chains were removed from decorin and biglycan with chondroitinase ABC and from fibromodulin with keratanase II, and the resulting core proteins were blotted to nitrocellulose followed by Western analysis [Figs. 2 (panel 2) and 3 (panel 3)], with quantitation using ECL ( Figs. 4 and 5) . No significant changes in decorin and biglycan contents from day 2 to day 16 were detected in control cultures (Fig. 4) . No This table presents an analysis of newly synthesized decorin in control and TGF beta 1-treated cultures on day 2 and on day 16, both with respect to quantitative differences and with respect to molecular weight. Cartilage was pulsed overnight on day 1 and on day 15. Urea extracts were purified by DEAE anion exchange chromatography, eluted with 0.3 and 1.0 M NaCl, and further separated by 5-15% SDS gradient gel electrophoresis. Dried gels were quantitated using a phosphorimager and MACBAS software yielding relative amounts of newly synthesized decorin. Differences between control and TGF beta 1-treated cultures were minimal at day 2, although some HMW decorin is already apparent in cultures treated with TGF beta 1. By day 16, decorin synthesis declined in controls, although some HMW decorin was detected. In contrast, synthesis of HMW decorin dramatically increased in TGF beta 1-treated cultures.
* HMW decorin has a mobility on SDS gels that is less than that of decorin from controls. significant changes were detected for fibromodulin either, but sample number (nϭ2) was limited. A small, but significant increase in decorin was detectable after 16 days of culture in the presence of TGF beta 1 (Fig. 5) . No significant change in biglycan was detected in response to TGF beta 1 (Fig. 5 ). Increases in fibromodulin in response to TGF beta 1 were the most extensive averaging 3.8-fold ( Fig. 5 ).
Discussion
Our goal was to study the effects of TGF beta 1 on the synthesis of three small PGs, decorin, biglycan, and fibromodulin by chondrocytes. To accomplish this, we chose the conditions as close as possible to in vivo conditions by using cartilage explants with an intact matrix, rather than isolated chondrocytes in culture. We focused on small PGs, specifically, by choosing culture conditions in which aggrecan synthesis was not, or was only minimally, affected 21 . Under these culture conditions, TGF beta 1 induces a marked increase in fibronectin synthesis, which is one characteristic of OA cartilage 21 . Thus, in these experiments, we looked at the effect of TGF beta 1 on small PGs under conditions which support some of the characteristics of the early OA phenotype. The entire cartilage used in this study was disease-free, but since donor animals came from a colony in which dogs of similar age and breed do develop osteoarthritic lesions, the cartilage may have been predisposed to develop OA. The source of this cartilage may facilitate comparison of these results with OA cartilage in the future. For the first time, we report a 3.8-fold increase in fibromodulin in canine articular cartilage in response to TGF beta 1, and we show that fibromodulin in canine articular cartilage is partially substituted with KS. The major newly synthesized small PG in cultures treated with TGF beta 1 had a greater molecular weight than endogenous decorin. This at first led to the hypothesis that cartilage explants synthesized a novel CS/DS small PG in response to TGF beta 32 . Subsequently, we identified the HMW small PG as decorin. First, the HMW small PG could be immunoprecipitated with an anti-decorin antibody, which is specific for decorin with no cross-reactivity with biglycan or fibromodulin in immunoblots 24 . Second, the HMW small PG has GAG chains 1.5-fold larger than those found in endogenous decorin, sufficient to account for the increase in molecular weight. To explain the HMW small PG, we could have postulated the presence of biglycan with a single GAG chain. However, although biglycan with a single GAG chain has a size similar to HMW decorin, we observed no evidence for co-precipitation of any biglycan with decorin in our experiments. Furthermore, it is not necessary to postulate biglycan with a single GAG chain to account for our results, which can also be explained by the longer GAG chains on decorin. The effect of TGF beta on GAG chain length has been reported previously; e.g., Chan and Anastassiades 33 reported an increase in length of chondroitin sulfate chains synthesized in the presence of TGF beta in high density bovine articular chondrocyte cultures.
In our experiments, the majority of newly synthesized small PGs in both control and TGF beta 1-treated explants was decorin. Some biglycan was detected. Newly synthesized, KS-substituted fibromodulin was below detectable levels. This is consistent with the findings of Roughley 34 that decorin synthesis greatly exceeds biglycan synthesis in adult humans and with the ratio of mRNAs reported by Cs-Szabó et al. 11 for adult human cartilage (decorin: biglycan:fibromodulinϭ158:8:1). It is also consistent with other experiments in our laboratory in which we have isolated pure decorin from large quantities of articular cartilage. Our estimated yield of 700 µg/g wet weight of tissue agrees well with reports of Rosenberg et al. 35 . Preliminary estimates put biglycan levels at 25-40% and fibromodulin levels at 7-15% of decorin.
The three-to four-fold increase in 35 SO 4 -decorin including 1.5-fold increase in chain length in response to TGF beta 1 from day 2 to day 16, with shift towards HMW decorin, had little or no impact on total endogenous decorin over this same time-period. Likewise, in control cultures, synthesis of decorin declined from day 2 to day 16, but no net decrease in total decorin content was observed by day 16 (Fig. 4) . Thus, we must consider whether or not newly synthesized decorin in culture and endogenous decorin represent the same metabolic pool, and/or whether the amount of decorin synthesized and lost during 2 weeks in culture represents only a small proportion of endogenous decorin. A half-life of 18 days has been reported for decorin in bovine collateral ligament 36 , but additional work is needed to establish this parameter for articular cartilage.
Endogenous fibromodulin content was more responsive to culture with TGF beta than decorin and biglycan contents. In one experiment, a difference of as much as seven-fold was noted. The greater net changes to fibromodulin mean that TGF beta can affect the relative composition of the small PGs with respect to each other. If fibromodulin has a role in fibrillogenesis of collagen type II, as has been demonstrated in transgenic mice for collagen type I fibrillogenesis 3 , changes in the stoichiometry of fibromodulin with respect to the other small PGs is likely to have significant consequences. KS chains are present on fibromodulin from bovine cartilage obtained from cows from 3 months to 8 years of age 37 . Fibromodulin in the human fetus and neonate is a diffuse population of molecules between 70 and 110 kDa, consistent with KS substitution. In the human adult, the electrophoretic pattern becomes more discrete at 67 kDa. This corresponds to fibromodulin devoid of KS, and in some instances, mature adult forms exist with neither KS nor the non-sulfated polylactosamine 22, 34 . Cartilage in this study came from the dogs that could be characterized as adolescent or young adult. Native fibromodulin with KS substitution as well as fibromodulin lacking KS were present in this cartilage. This is consistent with the reported composition of human cartilage of comparable age 38, 39 ; however, a function for these endogenous free-core proteins in cartilage has not been described.
Morales et al. 40 reported that, in vivo, articular cartilage contains a pool of TGF beta in excess of the amount of exogenous, active TGF beta that must be added to explants to affect the PG synthesis. However, most of this pool is sequestered and not readily accessible to the chondrocyte. The release and activation of this reserve after matrix degradation would allow for a role for TGF beta in the progression of OA and could account for osteophyte formation 17, 19 . Does this postulated release and activation of TGF beta actually occur in OA cartilage in vivo? If so, over the extended time it may take for TGF beta 1-induced changes in the cartilage matrix to accumulate, we would expect to see elevated fibromodulin levels and a HMW decorin in OA cartilage in vivo. In fact, increased fibromodulin is observed in canine spontaneous and ACL transection models, as well as in human cartilage 41 . One specimen consisting of visually intact knee cartilage taken from a canine knee joint that had extensive lesions did contain a HMW decorin. However, two mild OA lesions showed no evidence of a change in the size of decorin small PG. This question will require further study.
An association of TGF beta with the progression of OA is not intuitive. One expects an anabolic factor, such as TGF beta to contribute to matrix repair. TGF beta should antagonize catabolic agents and restore aggrecan synthesis. However, an increase in the synthesis of matrix components may not be beneficial if the appropriate balance cannot be maintained. Changes in the ratio of the small PGs in cartilage, with respect to each other and to aggrecan, could have a profound influence on the pathogenesis of OA. For example, changes in the cartilage composition of decorin and/or fibromodulin, which affect fibril diameter could account for an early observation by Lust et al. 42 , who reported that there is an absence of large diameter collagen fibrils in OA lesions in cartilage from dogs with canine hip dysplasia. Only medium and small diameter fibrils remain. Furthermore, fibronectin, including the cartilagespecific (VϩC) Ϫ fibronectin isoform, is also elevated in OA cartilage 43, 44 . This isoform was demonstrated to bind more decorin and biglycan than equivalent amounts of other isoforms 45 . Thus, it is possible that fibronectin-small PG complexes exist in OA cartilage to a degree in which they do not occur in disease-free cartilage, and this could influence matrix organization. Fibronectin-decorin interactions influence fibrillogenesis of type I collagen 5 and might have a similar role with respect to type II collagen. It is also interesting to note that sites capable of binding alpha 4 beta 1 integrins and small PGs have been found in close proximity on fibronectin, suggesting functional cooperativity 46 . Chondrocytes from OA cartilage acquire expression of the alpha 4 beta 1 integrin not normally present 47 . These cell and matrix changes are likely to be reflected in changes in gene expression in OA cartilage, but this remains speculation at this point.
